Plenty of money changed hands in pharma M&A during March, with the biggest deal a $6.7 billion merger between Mallinckrodt ...

Over the last several years, drugmakers have agreed to pay $57 billion in opioid settlements, including a landmark $26 ...

Mergers and acquisitions (M&As) are highly anticipated, high-stakes events. When successful, they are one of the fastest ways for organizations to accelerate growth and increase shareholder returns.

A $35 billion merger between Capital One and Discover that would make Capital One the nation’s largest credit card issuer cleared a major regulatory hurdle this week, according to multiple ...

Endo International is the latest drugmaker ... opioid settlement and corporate restructuring terms – as well as Mallinckrodt, which emerged from chapter 11 after agreeing a $1.6 billion ...

Specialist pharma company Mallinckrodt announced on 26 December that it is to acquire Sucampo Pharmaceuticals for around $1.2 billion. The company’s management are clearly looking to bring cheer ...

Musk’s splashy merger of the social-media company X and his artificial-intelligence startup xAI values the combined company at over $110 billion. That would be a blockbuster deal on Wall Street.